Pharmaceutical Industry Blog

Neostigmine + Glycopyrrolate Injection is a sterile parenteral fixed-dose combination of the cholinesterase inhibitor neostigmine methylsulfate (typically 2.5 mg) with the antimuscarinic glycopyrrolate (typically 0.5 mg) per ampoule. It is the global standard for routine reversal of non-depolarising neuromuscular blockade at the end of surgery.

Neostigmine Methylsulfate Injection is a sterile parenteral solution of the reversible cholinesterase inhibitor neostigmine methylsulfate, supplied as 0.5 mg/mL and 2.5 mg/mL in 1 mL ampoules. It is the global standard for reversal of non-depolarising neuromuscular blockade, symptomatic treatment of myasthenia gravis and postoperative urinary retention.

Phytomenadione (Vitamin K1) Injection is a sterile, ready-to-use parenteral solution of phytomenadione, supplied as 10 mg/mL in 1 mL ampoules and 2 mg/0.2 mL paediatric ampoules. It is the standard treatment and prophylaxis for vitamin-K-deficiency bleeding in newborns and for reversal of warfarin and other vitamin-K-antagonist anticoagulation.

Tranexamic Acid Injection is a sterile, ready-to-use parenteral antifibrinolytic supplied as 100 mg/mL in 5 mL (500 mg) and 10 mL (1,000 mg) ampoules. It is the first-line agent for controlling and preventing haemorrhage in obstetric, surgical, trauma, dental, urological and oncology settings, stabilising the fibrin clot to reduce blood loss.

Furosemide Injection is a sterile, ready-to-use parenteral solution of furosemide, supplied as 10 mg/mL in 2 mL and 4 mL ampoules (20 and 40 mg) and 25 mL multi-dose vials (250 mg). It is the rapid-onset loop diuretic of choice in acute pulmonary oedema, congestive heart failure, hypertensive crises and oliguric renal failure.

Sterile Water for Injection is a sterile, pyrogen-free, solute-free water for parenteral use, supplied in 5 mL, 10 mL and 20 mL ampoules and vials and in 50 mL to 1000 mL bags and bottles for reconstitution, dilution and irrigation. It is the universal vehicle that turns lyophilised antibiotics, oncology cytotoxics and emergency drugs into ready-to-administer medicines.